BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260203
DTEND;VALUE=DATE:20260206
DTSTAMP:20260515T010842
CREATED:20250919T104339Z
LAST-MODIFIED:20250919T104709Z
UID:41969-1770076800-1770335999@www.pharmajournalist.com
SUMMARY:14th Alzheimer's & Parkinson's Drug Development Summit
DESCRIPTION:Alzheimer’s and Parkinson’s pipelines are rapidly expanding beyond amyloid and into next-generation mechanisms such as α-synuclein\, neuroinflammation\, and metabolic targets. Against the backdrop of a globally surging patient population\, the urgency for more effective\, disease-modifying interventions has never been greater. \nIn its 14th year\, the Alzheimer’s and Parkinson’s Drug Development Summit is committed to spotlighting the latest trailblazing innovation\, from novel interventions for disease modification\, encompassing protein aggregation\, neuroinflammation\, metabolic pathways\, neurotrophic factors and more to the groundbreaking progress in p-tau217 and fluid-based biomarkers. \nThe 2026 program is built to explore disease progression\, modification and prodromal intervention\, so the next generation of therapeutics can prevent as well provide a meaningful impact to neurodegenerative patients in need. \nWhat can you expect? \n\n2 deep dive workshops into in vivo and in vitro modelling advancements\nSeminar day on fluid-based biomarker innovation\n30+ expert speakers including industry leaders\, academic KOLs and patient voices\nMultiple tracks of content spanning discovery\, preclinical\, clinical and regulatory\n10+ hours dedicated networking time over 3 days\n\nDon’t miss your opportunity to connect with leading drug developers and discover next-generation therapeutics redefining neurodegenerative treatment. \nFind out more here – https://ter.li/ybtrdq
URL:http://www.pharmajournalist.com/event/14th-alzheimers-parkinsons-drug-development-summit/
LOCATION:Hyatt Regency Boston Harbor\, 101 Harborside Drive\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260203
DTEND;VALUE=DATE:20260206
DTSTAMP:20260515T010842
CREATED:20251111T142214Z
LAST-MODIFIED:20251111T142214Z
UID:42355-1770076800-1770335999@www.pharmajournalist.com
SUMMARY:10th Liquid Biopsy for Precision Oncology Summit
DESCRIPTION:The past decade has transformed liquid biopsy\, which was previously just an exciting concept\, into a routine\, commercially viable technology that is saving patients’ lives and transforming clinical trials. \nUniting the field in San Diego February 3-5\, 2026 for 3 days of data- and strategy-driven presentations and networking sessions\, the 10th Liquid Biopsy for Precision Oncology Summit returns to deliver unparalleled insights\, data\, technology updates\, and strategies spanning the entire drug development pipeline – from preclinical discovery\, through clinical translation\, to regulatory approval\, reimbursement\, and commercial adoption. \nIf you are working in precision oncology\, or need enhanced insights into your patient population\, optimized diagnostic and prognostic tools\, or earlier detection of disease\, this meeting should be considered a staple entry in your conference calendar. Across ctDNA\, MRD\, multi-omic biomarkers\, and novel analytes\, you will see how pharma are strategically integrating liquid biopsies into therapeutic pipelines\, how diagnostic companies are designing more sensitive assays\, and how the field is overcoming barriers to widespread clinical adoption. \n\nSee the full event guide here: https://ter.li/nwkakw\nWith free* tickets available for biopharma\, visit the website to register: https://ter.li/2ewl2u\n\n*Subject to terms and conditions
URL:http://www.pharmajournalist.com/event/10th-liquid-biopsy-for-precision-oncology-summit/
LOCATION:San Diego Marriot La Jolla\, 4240 La Jolla Village Dr\, La Jolla\, CA\, 92037\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260203
DTEND;VALUE=DATE:20260206
DTSTAMP:20260515T010842
CREATED:20251111T143537Z
LAST-MODIFIED:20251111T143537Z
UID:42367-1770076800-1770335999@www.pharmajournalist.com
SUMMARY:2nd Proteomics-Based Drug Discovery Summit
DESCRIPTION:With Novartis committing $750M to ProFound Therapeutics to discover new cardiovascular candidates\, and Illumina acquiring SomaLogic for $425 to expand its proteomic capabilities just this year alone\, the increasing recognition of proteomics as a transformative force in drug discovery is unquestionable. \nReturning to Boston for its second year\, the Proteomics-Based Drug Discovery Summit is the premier industry event dedicated to harnessing the full power of proteomics across drug discovery pipelines. Designed for scientific innovators like you\, explore how next-generation proteomic platforms are accelerating understanding of pathology\, unveiling novel drug targets\, and transforming hit-to-lead development. \nWith a special focus on optimizing proteomics instruments to balance throughput and sensitivity\, automating sample processing\, unveiling hidden disease mechanisms with PTM analysis\, and defining gold-standard analysis methodologies; this forum is ideal for proteomics leaders aiming to expand the druggable proteome and achieve therapeutic options for diseases with unmet need. \nAs proteomics continues to evolve\, make headlines\, and revolutionize therapeutic development\, unite with 70+ Directors\, Vice Presidents and Experts in Proteomics\, Chemical Biology\, Mass Spectrometry and Bioinformatics to achieve protein level insights to advance your own discovery pipeline. \nTo know more visit: https://ter.li/t6xjio
URL:http://www.pharmajournalist.com/event/2nd-proteomics-based-drug-discovery-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR